Skip to content
10-Q

Quarterly Report

Natus Medical Inc

0000878526-21-000090

← back to feed
Filed
Aug 6, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 30, 2021 34.13M sh
Shares Diluted Q2 2021 · Jun 30, 2021 33.87M sh
Shares Diluted Q2 2021 · Jun 30, 2021 33.85M sh
Shares Diluted Q2 2021 · Jun 30, 2020 33.83M sh
Shares Diluted Q2 2021 · Jun 30, 2020 33.62M sh
Stock Repurchased Q2 2021 · Jun 30, 2021 $0
Stock Repurchased Q2 2021 · Jun 30, 2020 $10.5M
Capex Q2 2021 · Jun 30, 2021 $1.97M
Capex Q2 2021 · Jun 30, 2020 $6.93M
Operating Cash Flow Q2 2021 · Jun 30, 2021 $44.1M
Operating Cash Flow Q2 2021 · Jun 30, 2020 $9.61M
Long Term Debt Q2 2021 · Jun 30, 2021 $0
Long Term Debt Q2 2021 · Dec 31, 2020 $5.84M
Short Term Debt Q2 2021 · Jun 30, 2021 $0
Short Term Debt Q2 2021 · Dec 31, 2020 $50M
Cash And Equivalents Q2 2021 · Jun 30, 2021 $62.49M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $82.08M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $84.88M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $63.3M
Stockholders Equity Q2 2021 · Jun 30, 2021 $417.83M
Stockholders Equity Q2 2021 · Mar 31, 2021 $408.93M
Stockholders Equity Q2 2021 · Dec 31, 2020 $411.09M
Stockholders Equity Q2 2021 · Jun 30, 2020 $395.47M
Stockholders Equity Q2 2021 · Mar 31, 2020 $398.15M
Stockholders Equity Q2 2021 · Dec 31, 2019 $416.12M
Current Liabilities Q2 2021 · Jun 30, 2021 $102.46M
Current Liabilities Q2 2021 · Dec 31, 2020 $145.75M
Total Liabilities Q2 2021 · Jun 30, 2021 $138.39M
Total Liabilities Q2 2021 · Dec 31, 2020 $189.3M
Current Assets Q2 2021 · Jun 30, 2021 $245.7M
Current Assets Q2 2021 · Dec 31, 2020 $271.7M
Total Assets Q2 2021 · Jun 30, 2021 $556.22M
Total Assets Q2 2021 · Dec 31, 2020 $600.39M
Eps Diluted Q2 2021 · Jun 30, 2021 $0.10
Eps Diluted Q2 2021 · Jun 30, 2021 $0.17
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.26
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.37
Eps Basic Q2 2021 · Jun 30, 2021 $0.10
Eps Basic Q2 2021 · Jun 30, 2021 $0.17
Eps Basic Q2 2021 · Jun 30, 2020 −$0.26
Eps Basic Q2 2021 · Jun 30, 2020 −$0.37
Sga Expense Q2 2021 · Jun 30, 2021 $12.61M
Sga Expense Q2 2021 · Jun 30, 2021 $27.46M
Sga Expense Q2 2021 · Jun 30, 2020 $11.19M
Sga Expense Q2 2021 · Jun 30, 2020 $24.37M
Rd Expense Q2 2021 · Jun 30, 2021 $14.25M
Rd Expense Q2 2021 · Jun 30, 2021 $28.29M
Rd Expense Q2 2021 · Jun 30, 2020 $14.34M
Rd Expense Q2 2021 · Jun 30, 2020 $31.91M
Net Income Q2 2021 · Jun 30, 2021 $3.46M
Net Income Q2 2021 · Jun 30, 2021 $5.86M
Net Income Q2 2021 · Mar 31, 2021 $2.4M
Net Income Q2 2021 · Jun 30, 2020 −$8.9M
Net Income Q2 2021 · Jun 30, 2020 −$12.5M
Net Income Q2 2021 · Mar 31, 2020 −$3.6M
Operating Income Q2 2021 · Jun 30, 2021 $6.01M
Operating Income Q2 2021 · Jun 30, 2021 $10.54M
Operating Income Q2 2021 · Jun 30, 2020 −$12.04M
Operating Income Q2 2021 · Jun 30, 2020 −$15.27M
Gross Profit Q2 2021 · Jun 30, 2021 $66.4M
Gross Profit Q2 2021 · Jun 30, 2021 $132.89M
Gross Profit Q2 2021 · Jun 30, 2020 $40.55M
Gross Profit Q2 2021 · Jun 30, 2020 $103.34M
Revenue Q2 2021 · Jun 30, 2021 $115.98M
Revenue Q2 2021 · Jun 30, 2021 $230.9M
Revenue Q2 2021 · Jun 30, 2020 $84.78M
Revenue Q2 2021 · Jun 30, 2020 $194.16M